1. Home
  2. SLS vs VCSA Comparison

SLS vs VCSA Comparison

Compare SLS & VCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • VCSA
  • Stock Information
  • Founded
  • SLS 2012
  • VCSA 2009
  • Country
  • SLS United States
  • VCSA United States
  • Employees
  • SLS N/A
  • VCSA N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • VCSA Computer Software: Prepackaged Software
  • Sector
  • SLS Health Care
  • VCSA Technology
  • Exchange
  • SLS Nasdaq
  • VCSA Nasdaq
  • Market Cap
  • SLS 89.6M
  • VCSA 82.3M
  • IPO Year
  • SLS N/A
  • VCSA N/A
  • Fundamental
  • Price
  • SLS $1.09
  • VCSA $5.39
  • Analyst Decision
  • SLS
  • VCSA Hold
  • Analyst Count
  • SLS 0
  • VCSA 3
  • Target Price
  • SLS N/A
  • VCSA $5.00
  • AVG Volume (30 Days)
  • SLS 815.8K
  • VCSA 169.5K
  • Earning Date
  • SLS 03-20-2025
  • VCSA 05-08-2025
  • Dividend Yield
  • SLS N/A
  • VCSA N/A
  • EPS Growth
  • SLS N/A
  • VCSA N/A
  • EPS
  • SLS N/A
  • VCSA N/A
  • Revenue
  • SLS N/A
  • VCSA $910,485,000.00
  • Revenue This Year
  • SLS N/A
  • VCSA N/A
  • Revenue Next Year
  • SLS N/A
  • VCSA $2.77
  • P/E Ratio
  • SLS N/A
  • VCSA N/A
  • Revenue Growth
  • SLS N/A
  • VCSA N/A
  • 52 Week Low
  • SLS $0.77
  • VCSA $2.07
  • 52 Week High
  • SLS $1.84
  • VCSA $8.19
  • Technical
  • Relative Strength Index (RSI)
  • SLS 40.56
  • VCSA 57.64
  • Support Level
  • SLS $1.13
  • VCSA $5.34
  • Resistance Level
  • SLS $1.25
  • VCSA $5.43
  • Average True Range (ATR)
  • SLS 0.07
  • VCSA 0.14
  • MACD
  • SLS -0.01
  • VCSA -0.01
  • Stochastic Oscillator
  • SLS 17.39
  • VCSA 53.57

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About VCSA Vacasa Inc.

Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.

Share on Social Networks: